1.

Which of the following has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19?

A. Glenmark Pharmaceuticals
B. Cadila Healthcare
C. Sun Pharma
D. Cipla
E. Lupin Limited
Answer» B. Cadila Healthcare


Discussion

No Comment Found